Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Atkins

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cell Reports. Medicine|February 22, 2023
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinomaJulie Stein Deutsch, Evan J Lipson, Ludmila Danilova, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Modeling human B cell development with pluripotent stem cellsXiaoning Sun, Jamie J Kwan, Krishna Kothari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2Wei Wang, Amy K Erbe, Mikayla Gallenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell CarcinomaAmy K Erbe, Wei Wang, Jacob Goldberg, et al.
Cell Reports|April 11, 2019
Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate DependenciesBarbara Mair, Jelena Tomic, Sanna N Masud, et al.
Cancer Immunology Research|March 13, 2016
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCCAndrew Gabrielson, Yunan Wu, Hongkun Wang, et al.
Melanoma Research|November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|August 22, 2024
Limitations of Triage in Military Mass Casualty Response: A Case SeriesStephen C Rush, Michael J Lauria, Erik Scott DeSoucy, et al.
Journal of Translational Medicine|December 2, 2015
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014Paolo A Ascierto, Michael Atkins, Carlo Bifulco, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cell Reports. Medicine|February 22, 2023
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinomaJulie Stein Deutsch, Evan J Lipson, Ludmila Danilova, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Modeling human B cell development with pluripotent stem cellsXiaoning Sun, Jamie J Kwan, Krishna Kothari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2016
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2Wei Wang, Amy K Erbe, Mikayla Gallenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2016
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell CarcinomaAmy K Erbe, Wei Wang, Jacob Goldberg, et al.
Cell Reports|April 11, 2019
Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate DependenciesBarbara Mair, Jelena Tomic, Sanna N Masud, et al.
Cancer Immunology Research|March 13, 2016
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCCAndrew Gabrielson, Yunan Wu, Hongkun Wang, et al.
Melanoma Research|November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|August 22, 2024
Limitations of Triage in Military Mass Casualty Response: A Case SeriesStephen C Rush, Michael J Lauria, Erik Scott DeSoucy, et al.
Journal of Translational Medicine|December 2, 2015
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014Paolo A Ascierto, Michael Atkins, Carlo Bifulco, et al.
Pageof 6